SynthesisBreast cancer research and treatment2026
The impact of menopausal status on the efficacy of adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: a systematic review and meta-analysis of phase III clinical trials.
Uri Bender et al.PubMed ↗Publisher ↗
No numbers read from the abstract.